Yijing Capital

Yijing Capital is an investment company focuses on the medical and health-care sector.

Business Model:

Revenue: $0

Employees: 0-0

Rankings

Detailed Yijing Capital Information

Geographic Data

Yijing Capital headquarters map

Address:

City:

State:

Zip:

Country:

Financial Info

Stage:

Raised Last:

$0

Raised Total:

$0

Metrics

0Website Global Rank

0Website Monthly Traffic

Twitter Followers

Description

Yijing Capital is an investment company focuses on the medical and health-care sector. Shanghai Yijing Investment Co. Ltd. was founded in 2015 as a sister company of Yizhou Group, which is among China’s Top 500 companies and has accumulated decades of experience in multiple industries. Yijing owns multiple investment platforms, undertaking equity investment with both self-owned and externally sourced funds. Yijing is positioned as a professional investment company with global footprint. The Yijing core team is equipped with years of operational and managerial expertise both at home and abroad. They mainly invest in industries with high growth potential. Currently, they have completed a dozen of investment projects domestically and internationally, covering sectors including smart manufacturing, medical and health-care, AI, new retail, education and new energy. Their investment will focus more on the medical and health-care sector, and also smart manufacturing. Most companies they have invested in are growing robustly and some have gone public, and they also have exited some companies with robust return.

Contact Phone:

Contact Email:

Announced Date Company Transaction Money Raised
5/2019 EO Company Series C 11.6M
3/2021 Keythera Pharmaceuticals Series A 15.4M
12/2020 Raynovent Series B 42.8M
11/2019 independence Day Series B 2.9M
1/2021 Oricell Therapeutics Series A 0
3/2018 Veritas Genetics Venture Round 4.6M
9/2021 Immunophage Biotech Series A -
10/2019 Yidebang Series B 14.1M
6/2020 eTheRNA immunotherapies Series B 0
1/2022 InnoStar Semiconductor Series A -
10/2020 Leto Laboratories Series B 14.9M
5/2021 Kangpu Biopharmaceuticals, Ltd. Series B 0
4/2018 EO Company Series B 10.2M
10/2021 ChosenMed Series C -
4/2021 Tasogare Series B 41.1M
7/2022 Zhongguancun Shuimu Medical Series A 14.8M
4/2022 Leisen Electronic Technology Venture Round -
11/2017 EO Company Series B -
2/2023 NowYonMedical Venture Round -
11/2020 Zhiketong Technology Series D 50M
3/2021 Biren Technology Series B -
11/2018 Shanutec Series B 7.2M
10/2021 Natural Melody Series B 31.3M
10/2021 Walnut Computer Technology Series A -
1/2022 Bivision Seed Round -
11/2021 Xgene Pharmaceutical Series C 0
3/2021 Artivila Therapeutics Seed Round 22.8M
3/2022 CytoNiche Series B 0
7/2022 Zhongguancun Shuimu Medical Series A 0
4/2022 Leisen Electronic Technology Venture Round -
3/2022 CytoNiche Series B 0
1/2022 InnoStar Semiconductor Series A -
11/2021 Xgene Pharmaceutical Series C 0
10/2021 Natural Melody Series B 0
10/2021 Walnut Computer Technology Series A -
10/2021 ChosenMed Series C -
9/2021 Immunophage Biotech Series A -
5/2021 Kangpu Biopharmaceuticals, Ltd. Series B 0

Startup Industries

Startup Locations

Portfolio Current Status

Portfolio Employee Count

Name Price
Name Size Announced Date

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research